BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Lone Star Bio

  Asuragen, Inc. Launches Signature(R) LTx (Leukemia Translocation Panel) Globally

  April 23, 2008

   · 

  1 min read
• Drug Development

  Amkor Pharma, Inc. Completes All Clinical Activities for Its Phase I Study of Neu2000KL for Treatment of Acute Brain Injury

  April 23, 2008

   · 

  1 min read
• Drug Development

  Idenix Pharmaceuticals, Inc. Presents Positive Preclinical Data on HCV Programs

  April 23, 2008

   · 

  5 min read
• Business

  Sigma-Aldrich Corporation Raises 2008 Diluted EPS Forecast by $.05 to $2.57-$2.67. Reports Q1 2008 Diluted EPS Up 14.3%; Sales Gain of 14.9%

  April 23, 2008

   · 

  16 min read
• Drug Development

  Romark Laboratories, L.C. Announces Presentation of New Data for Nitazoxanide in Chronic Hepatitis C at EASL 2008

  April 23, 2008

   · 

  3 min read
• Business

  Ceregene, Inc. Announces Two Key Additions to Leadership Team

  April 23, 2008

   · 

  3 min read
• Business

  Edwards Lifesciences Corporation Reports Strong First Quarter Results and Raises 2008 Guidance

  April 23, 2008

   · 

  11 min read
• Business

  New Fragment-based Drug Discovery Platform Announced Between IOTA Pharmaceuticals and Beactica AB

  April 23, 2008

   · 

  1 min read
• BioCapital

  EntreMed, Inc. Will Not Seek Shareholder Approval for Reverse Stock Split at Annual Meeting

  April 23, 2008

   · 

  3 min read
• Provectus Pharmaceuticals Inc. Will Present at Inaugural LD MICRO Conference

  April 23, 2008

   · 

  1 min read